TLDR
- Lyophilization, also called freeze-drying, removes water from a frozen sample under reduced pressure.
- The process has three major stages: freezing, primary drying, and secondary drying.
- During primary drying, frozen water is removed mainly through sublimation, meaning ice changes directly from solid to vapor.
- Secondary drying removes additional unfrozen or bound water through desorption.
- Removing water can slow many chemical degradation reactions and reduce molecular mobility, which can improve the storage stability of some peptides.
- Freeze-drying does not automatically make every peptide stable. Freezing and dehydration can themselves create stress.
- Formulation components such as sucrose, trehalose, buffers, amino acids, and bulking agents may be used to improve product stability and physical properties.
- A lyophilized peptide still contains some residual moisture and can still undergo degradation during storage.
Lyophilized peptides have a distinctive appearance. Instead of a liquid, the material commonly forms a light, porous solid or “cake” inside a vial.
That solid did not form by simply allowing the water to evaporate.
It was produced through a carefully controlled process involving freezing, vacuum, heat transfer, sublimation, and final drying.
The process is called lyophilization, more commonly known as freeze-drying.
For peptides and other molecules that may have limited stability in aqueous solution, lyophilization can provide an important way to reduce chemical degradation and improve storage stability. But freeze-drying is not inherently protective. An improperly designed process can damage the material it is intended to preserve.
Understanding lyophilization therefore means understanding both sides of the process.
What Is Lyophilization?
Lyophilization is a drying process in which a solution is first frozen and then placed under reduced pressure so that frozen solvent can be removed primarily through sublimation.
Sublimation occurs when a substance changes directly from a solid to a gas without first becoming a liquid.
For an aqueous peptide formulation, the basic idea is:
Liquid solution → frozen solution → ice removed by sublimation → dry porous solid
Pharmaceutical freeze-drying is widely used for heat- and moisture-sensitive materials, including peptides, proteins, vaccines, and certain antibiotics.
The process usually contains three distinct stages:
- freezing;
- primary drying;
- secondary drying.
Each stage can influence the properties of the final material.
Why Remove Water From a Peptide?
Water is essential to biological chemistry.
It can also facilitate degradation.
In solution, peptide molecules and reactive chemical species have substantial molecular mobility. Reactions can occur through mechanisms such as:
- hydrolysis
- oxidation
- deamidation
- isomerization
- aggregation
Not every reaction requires water directly, and freeze-drying does not eliminate every degradation pathway.
But reducing water content and molecular mobility can greatly slow many reactions.
For this reason, pharmaceutical molecules that do not remain adequately stable in aqueous solution are sometimes developed as lyophilized solids. Reviews of biopharmaceutical drying describe improved solid-state stability as one of the major reasons for using freeze-drying.
The key word is can.
Lyophilization improves stability only when the molecule, formulation, process, packaging, and storage conditions work together.
Step 1: Freezing the Peptide Solution
The first step sounds straightforward.
The peptide solution is cooled until water freezes.
But this stage is more complicated than putting a vial in a freezer.
As ice forms, nearly pure water molecules enter the growing ice crystals.
Most dissolved substances do not fit into the ice crystal lattice.
That means the remaining unfrozen portion of the solution becomes increasingly concentrated.
The peptide, buffers, salts, sugars, and other solutes can become concentrated into progressively smaller regions between ice crystals.
This phenomenon is sometimes called freeze concentration.
Local changes can occur in:
- peptide concentration
- ionic strength
- pH
- viscosity
- excipient concentration
These changes can stress peptides and proteins.
The freezing step therefore has a major influence on both subsequent drying behavior and final product quality. A detailed review of pharmaceutical lyophilization describes freezing as one of the most complex parts of the process because it affects ice morphology, residual moisture, reconstitution, drying performance, and molecular stability.
Ice Crystal Size Matters
The ice created during freezing eventually leaves empty spaces when it sublimes.
Those spaces form pores in the dried cake.
So the size and distribution of ice crystals can influence the physical structure of the final lyophilized material.
Larger ice crystals generally leave larger channels.
Those channels can allow water vapor to escape more easily during primary drying.
Smaller ice crystals can create smaller pores and greater resistance to vapor flow.
This means freezing conditions can influence how long the product takes to dry.
Cooling rate, supercooling, nucleation temperature, formulation composition, and annealing can all affect ice structure.
Freeze-drying is therefore an interconnected process.
What happens during freezing can affect the next two stages.
What Is Supercooling?
Water does not necessarily freeze exactly when its temperature crosses 0°C.
A solution can cool below its equilibrium freezing temperature before ice crystals actually begin to form.
This condition is called supercooling.
Eventually, an ice nucleus forms.
Rapid crystal growth may then occur.
The degree of supercooling can affect how many ice crystals form and how large they become.
More extensive supercooling tends to produce a larger number of smaller ice crystals.
Controlled nucleation technologies have therefore been investigated as a way to improve consistency between vials and make pharmaceutical lyophilization more predictable.
What Is Annealing?
Some lyophilization processes include an annealing step after initial freezing.
The frozen product is temporarily held at a higher subzero temperature.
This can allow ice crystals to grow and can encourage certain formulation components to crystallize.
The product is then cooled again before primary drying.
Annealing is not appropriate or necessary for every formulation.
But when properly designed, it can alter ice structure, shorten drying time, and affect final cake properties.
Step 2: Primary Drying
After the solution is frozen, the lyophilizer reduces the pressure inside the drying chamber.
Controlled heat is then supplied to the frozen product.
Under these low-pressure conditions, ice can undergo sublimation.
Instead of melting into liquid water, the ice changes directly into water vapor.
The vapor moves out of the vial and toward the lyophilizer’s condenser, where it is captured as ice.
Primary drying removes the majority of frozen water.
This is generally the longest stage of the lyophilization cycle and often represents the primary limitation on manufacturing time.
The Product Is Heated During Freeze-Drying
The name “freeze-drying” can make it sound as though the product simply remains extremely cold while water disappears.
In reality, heat is required.
Sublimation consumes energy.
The shelves of the lyophilizer therefore supply controlled heat to the product during primary drying.
The challenge is balancing two competing needs.
The product needs enough heat to drive sublimation efficiently.
But too much heat can raise its temperature above important structural limits.
This balance is one of the central engineering problems in lyophilization.
What Is Collapse Temperature?
Many peptide formulations contain a concentrated, noncrystalline phase after freezing.
This phase may behave like an amorphous glass.
If the temperature becomes too high during primary drying, the dried structure can soften and lose its mechanical stability.
The porous cake can then shrink or collapse.
The temperature above which this becomes a concern is often described using a collapse temperature, usually written as Tc.
Amorphous formulations also have a characteristic glass-transition temperature of the maximally freeze-concentrated phase, commonly written as Tg’.
The product temperature during primary drying is generally controlled with these critical thermal properties in mind.
Crystalline formulations behave differently and may instead be limited by a eutectic melting temperature.
These properties are measured during formulation development rather than assumed.
What Does a Good Lyophilized Cake Look Like?
A successful lyophilized product often forms a porous solid that roughly retains the shape of the material in the vial.
Researchers may evaluate visual characteristics such as:
- cake height
- uniformity
- cracking
- shrinkage
- collapse
- discoloration
- meltback
But visual appearance is only one quality attribute.
A beautiful cake does not automatically mean the peptide is chemically intact.
Likewise, cosmetic cracking of a cake does not necessarily prove that the peptide has degraded.
Physical appearance and molecular stability need to be evaluated independently.
Step 3: Secondary Drying
Primary drying removes ice.
But even after all visible ice has sublimed, the product still contains water.
Some water molecules remain associated with the dried material.
Secondary drying is designed to remove a substantial portion of this remaining water through desorption.
During secondary drying:
- pressure remains low;
- product temperature is usually increased;
- residual water desorbs from the solid matrix.
The goal is not typically to remove literally every water molecule.
Instead, formulation scientists aim for a residual moisture range associated with acceptable stability and product performance.
Why Residual Moisture Matters
Water can act as a plasticizer in amorphous solids.
In simple terms, additional water can increase molecular mobility within the dried matrix.
Higher molecular mobility can accelerate some degradation pathways.
This is one reason excessive residual moisture can reduce solid-state stability.
But less water is not always automatically better.
For some biological molecules and formulations, extremely aggressive drying can also affect stability.
The optimum residual moisture level is formulation-specific.
This is another reason that scientifically meaningful lyophilization focuses on a validated process rather than simply trying to make a product “as dry as possible.”
Freeze-Drying Does Not Completely Stop Degradation
Lyophilization slows molecular motion and removes much of the water needed for certain reactions.
It does not suspend chemistry entirely.
A lyophilized peptide can still undergo:
- oxidation
- deamidation
- isomerization
- aggregation
- other chemical changes
Rates may increase with temperature and residual moisture.
Oxygen in the vial headspace, light exposure, reactive impurities, excipients, and packaging can also affect stability.
For that reason, lyophilized materials still require stability testing.
A dry appearance alone does not establish long-term stability.
Freezing Can Itself Damage Peptides and Proteins
The paradox of lyophilization is that the process used to improve storage stability can create its own stresses.
During freezing:
- ice-water interfaces form;
- solutes become concentrated;
- pH can shift;
- ionic strength can increase;
- molecular crowding changes.
During drying:
- the hydration shell surrounding a molecule is disrupted;
- molecular interactions change;
- the molecule enters a highly concentrated solid environment.
Proteins are particularly sensitive because these changes can disrupt higher-order structure.
Peptides are often smaller and may have less complex tertiary structure, but they are not automatically immune to freeze-drying stress.
Sequence, conformation, concentration, formulation, and chemical modifications all matter. Reviews of peptide and protein formulation identify lyophilization itself as one of several stress conditions that can influence molecular stability.
Why Sugars Such as Sucrose and Trehalose Are Used
Freeze-dried formulations often contain excipients designed to protect the active molecule.
Two widely studied examples are:
sucrose
and
trehalose
These disaccharides are commonly described as cryoprotectants, lyoprotectants, or both.
Two major theories help explain their protective effects.
Water Replacement
Before drying, water molecules form hydrogen bonds with polar groups on peptides and proteins.
When water is removed, sugars may form hydrogen-bonding interactions with some of those groups.
This can partly replace interactions previously provided by water.
Vitrification
Sugars such as sucrose and trehalose can form amorphous glassy matrices.
The peptide becomes embedded in this rigid matrix.
Low molecular mobility can then slow conformational changes and chemical reactions.
These two mechanisms are not necessarily mutually exclusive. Both are commonly discussed in the scientific literature on stabilization during freeze-drying.
Cryoprotectant vs. Lyoprotectant
The terms are related but describe different stages of protection.
A cryoprotectant primarily helps protect a molecule from stresses associated with freezing.
A lyoprotectant primarily helps protect a molecule during dehydration and in the dried state.
Some excipients perform both roles.
Sucrose and trehalose are common examples.
The appropriate excipient depends on the molecule and formulation.
There is no universal stabilizer that works best for every peptide.
What Are Bulking Agents?
The amount of peptide in a vial can be very small.
Freeze-drying a solution containing only a small quantity of peptide may produce a fragile or nearly invisible solid.
A bulking agent adds solids and can help create a more mechanically robust cake.
Common bulking agents in pharmaceutical lyophilization can include materials such as:
- mannitol
- glycine
Bulking agents do not necessarily behave like stabilizing sugars.
For example, mannitol often crystallizes during freeze-drying.
A crystalline bulking agent can provide excellent cake structure but may not offer the same glass-forming stabilization as amorphous sucrose or trehalose.
Formulations may therefore combine excipients for different purposes.
Buffer Selection Also Matters
Peptide formulations commonly contain buffers to control pH.
But freezing can complicate buffer behavior.
As water crystallizes, different buffer components can concentrate or crystallize at different rates.
This can cause the pH of the remaining unfrozen phase to shift.
Phosphate-buffered formulations are a classic example in protein formulation science because selective crystallization of one phosphate species can produce substantial pH changes during freezing under certain conditions.
A buffer that works well in a room-temperature solution is therefore not automatically ideal for a freeze-dried formulation.
Formulation development needs to consider behavior during the entire freezing and drying process.
Why Lyophilized Material Is Porous
The porous structure of a lyophilized cake is a direct consequence of ice sublimation.
Think of the frozen product as two interpenetrating regions:
ice crystals
and
freeze-concentrated solute
During primary drying, the ice disappears.
The spaces once occupied by ice remain as pores.
Those pores create channels through the solid.
This high surface area is one reason a properly designed lyophilized material can often dissolve relatively quickly when an appropriate solvent is added during a legitimate laboratory or pharmaceutical procedure.
Pore size and cake morphology are heavily influenced by the original freezing step.
Lyophilization and Reconstitution Are Connected
Reconstitution behavior is one quality attribute studied during development of lyophilized pharmaceutical products.
Researchers may evaluate:
- reconstitution time
- clarity
- visible particles
- subvisible particles
- aggregation
- concentration
- biological activity
A cake that reconstitutes slowly may indicate a formulation or physical-structure issue.
But appearance alone cannot determine whether the original peptide has remained chemically intact.
Analytical testing is still required.
Why Lyophilized Peptide Reference Standards Are Used
Freeze-drying is not limited to commercial pharmaceutical products.
It is also useful for analytical reference standards.
USP researchers have described preparation of synthetic peptide reference standards involving:
- characterization of bulk peptide;
- preparation of a solution;
- dispensing into individual vials;
- lyophilization;
- value assignment;
- uniformity and stability testing.
The goal is to produce individual reference vials containing reproducible quantities of well-characterized material.
This is a good example of lyophilization as an analytical tool rather than simply a formulation technology.
Lyophilized Does Not Mean 100% Peptide
A dried peptide vial can contain several components.
These may include:
- the peptide
- counterions
- stabilizers
- buffers
- bulking agents
- residual water
- trace residual solvents
This means the total dry mass does not necessarily equal peptide mass.
The same distinction discussed in peptide purity testing applies here.
Lyophilized mass is not automatically peptide content.
Reference-standard characterization often accounts separately for water, counterions, impurities, and other components when determining actual peptide content.
Lyophilized Does Not Mean Sterile
Lyophilization is also not a sterilization method.
Removing water does not establish:
- sterility
- endotoxin status
- absence of microorganisms
- absence of particulates
Sterile pharmaceutical freeze-drying requires tightly controlled aseptic manufacturing processes and validated microbiological controls.
A research material being freeze-dried tells you how water was removed.
It does not tell you its microbiological status.
Lyophilized Does Not Mean Stable Forever
Another common misconception is that a freeze-dried molecule becomes permanently stable.
It does not.
Solid-state degradation still occurs.
Shelf life depends on factors including:
- peptide sequence
- formulation
- residual moisture
- oxygen
- light
- temperature
- packaging
- storage duration
Stability has to be established experimentally.
Lyophilization is a strategy for improving stability, not a guarantee of indefinite preservation.
How Scientists Develop a Lyophilization Cycle
A pharmaceutical freeze-drying cycle is not ideally chosen by trial and error alone.
Development commonly begins by characterizing the formulation’s thermal properties.
Researchers may use techniques such as:
- differential scanning calorimetry
- freeze-dry microscopy
- electrical resistance measurements
- other thermal analytical methods
They then design:
- freezing temperature
- cooling rate
- annealing conditions where appropriate
- chamber pressure
- shelf temperature
- primary drying duration
- secondary drying temperature
- secondary drying duration
Scientific lyophilization design aims to dry the material efficiently while keeping product temperature within acceptable limits.
Modern approaches increasingly use heat- and mass-transfer modeling to predict primary drying behavior and define a robust process design space.
How Researchers Evaluate the Final Lyophilized Material
A freeze-drying experiment is not complete simply because a dry cake appears.
Researchers can examine several attributes.
Physical Appearance
Is the cake intact, collapsed, shrunken, cracked, or discolored?
Residual Moisture
How much water remains?
Reconstitution Properties
How readily does the material return to solution under the defined test procedure?
Chemical Purity
Has the peptide degraded?
HPLC and LC-MS may be used here.
Identity
Is the target peptide still chemically intact?
Aggregation
Has the molecule formed larger assemblies?
Biological Activity
If relevant, does the peptide retain its expected function?
The appropriate tests depend on the molecule and research objective.
Freeze-Drying Is a Balance of Competing Factors
Lyophilization sounds like a simple preservation technique:
freeze something and remove the water.
The actual science is much more interesting.
Freezing protects the product from heat but creates concentration and interface stresses.
Lower temperatures protect molecular structure but can dramatically slow drying.
Higher temperatures speed sublimation but can collapse the cake.
Removing water can improve storage stability, but excessive or poorly controlled drying can also create problems.
Excipients can protect the peptide, but they also change the physical properties of the formulation.
Good lyophilization therefore depends on balancing:
molecular stability
with
physical stability
and
process efficiency.
That is why freeze-drying is not simply a storage step added at the end of peptide synthesis.
It is a formulation and process-science problem of its own.
FAQs
Is Lyophilization the Same as Freeze-Drying?
Yes. The terms lyophilization and freeze-drying generally refer to the same process.
Why Are Peptides Lyophilized?
Some peptides have greater storage stability in a dry state than in aqueous solution. Removing much of the water can reduce molecular mobility and slow several degradation pathways.
Does Freeze-Drying Use Heat?
Yes. Controlled heat is supplied during drying because sublimation requires energy. The product remains under reduced pressure, and its temperature is carefully managed.
What Are the Three Stages of Lyophilization?
The main stages are freezing, primary drying, and secondary drying. Primary drying removes ice through sublimation. Secondary drying removes additional residual water through desorption.
Does Lyophilization Remove All Water?
No. A lyophilized material normally retains some residual moisture. The target level depends on the formulation and its stability requirements.
Why Are Sucrose and Trehalose Used in Freeze-Drying?
They can help protect peptides and proteins during freezing and dehydration and can form a glassy matrix that reduces molecular mobility in the dried material.
What Is a Lyophilized Cake?
It is the porous solid left behind after frozen water has been removed from a formulation. Its pores largely correspond to spaces previously occupied by ice crystals.
Can Lyophilization Damage a Peptide?
Yes. Freezing and dehydration create physical and chemical stresses. Formulation and process conditions need to be optimized for the molecule.
Does Lyophilization Make a Peptide Sterile?
No. Freeze-drying is not a sterility test or a sterilization process.
Does Lyophilization Guarantee Long-Term Stability?
No. It can improve stability, but lyophilized peptides can still degrade. Long-term stability needs to be determined experimentally.
References
- Kasper JC, Friess W. The Freezing Step in Lyophilization: Physico-Chemical Fundamentals, Freezing Methods and Consequences on Process Performance and Quality Attributes of Biopharmaceuticals. European Journal of Pharmaceutics and Biopharmaceutics. 2011. PubMed
- Pisano R, et al. Practical Advice on Scientific Design of Freeze-Drying Process: 2023 Update. Pharmaceutical Research. 2023. PubMed
- Butreddy A, et al. Instability of Therapeutic Proteins: An Overview of Stresses, Stabilization Mechanisms and Analytical Techniques Involved in Lyophilized Proteins. International Journal of Biological Macromolecules. PubMed
- Akbarian M, Chen SH. Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins. Pharmaceutics. 2022. PubMed
- Bhatnagar BS, et al. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations. PubMed
- McCarthy D, Han Y, Carrick K, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research. 2023. PubMed
- McCarthy D, Han Y, Carrick K, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. USP full-text version. United States Pharmacopeia
- Wang W, et al. Pharmaceutical Protein Solids: Drying Technology, Solid-State Characterization and Stability. Full text at PubMed Central
- Emami F, et al. Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals. Pharmaceutics. 2018. Full text at PubMed Central
- Capozzi LC, et al. New Trends in Freeze-Drying of Pharmaceutical Products. Pharmaceutics. 2023. Full text at PubMed Central
- Chang LL, et al. Practical Advice in the Development of a Lyophilized Protein Drug Product. 2024. PubMed